Budget Amount *help |
¥4,680,000 (Direct Cost: ¥3,600,000、Indirect Cost: ¥1,080,000)
Fiscal Year 2019: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2018: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2017: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
|
Outline of Final Research Achievements |
To generate pluripotent stem cells (PSCs)-derived vascular endothelial cells in vivo, we performed blastocyst complementation with injecting PSCs into Flk-1 deficient mouse blastocyst. This Flk-1 deficient is embryonic lethal due to an early defect in endothelial and hematopoietic cells. In this study, we successfully generated vascular endothelial cells and blood derived from mouse PSCs (ES/iPS cells) in Flk-1 deficient chimeric mice by blastocyst complementation. And the Flk-1 deficient chimeric mice survived to adulthood without any abnormality. Based on the above, this study achieved "Development of vascular endothelium reconstitution method in organ ".
|